Literature DB >> 22341945

The Schizophrenia and Bipolar Disorder associated BRD1 gene is regulated upon chronic restraint stress.

Jane H Christensen1, Betina Elfving, Heidi K Müller, Tue Fryland, Mette Nyegaard, Thomas J Corydon, Anders Lade Nielsen, Ole Mors, Gregers Wegener, Anders D Børglum.   

Abstract

Recent genetic evidence has implicated the bromodomain containing 1 gene (BRD1) with brain development and susceptibility to Schizophrenia and Bipolar Disorder. The BRD1 protein, which is essential for acetylation of histone H3K14, is a putative regulator of transcription during brain development and in the mature CNS. However, several issues remain to be clarified for example regarding the regulation of the BRD1 gene upon environmental interventions. Chronic restraint stress (CRS) in rats represents an environmental method for induction of morphological and functional changes in the hippocampus and the prefrontal cortex. In order to investigate whether the expression of the rat Brd1 gene may be regulated during such conditions, Brd1 mRNA and protein levels in hippocampus and prefrontal cortex extracts from rats subjected to either 1/2 or 6h of CRS per day for 21days were measured. We found a significant 2-fold up-regulation of long exon 7 splice variants of the Brd1 gene (Brd1-L) in hippocampus in both groups of CRS rats compared to controls. Concomitantly, we found a similar up-regulation of the BRD1 protein. In prefrontal cortex, we found no significant differences in Brd1 mRNA or protein levels. As selective histone deacetylase (HDAC) inhibitors not only preserve stress-induced hyperacetylation of histone H3K14 but also have hippocampal-dependent antidepressant-like activity, we propose that BRD1 by its intrinsic acetylation activity towards histone H3K14 is a player in the regulatory processes underlying adaptation to stress in the mature CNS.
Copyright © 2012 Elsevier B.V. and ECNP. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22341945     DOI: 10.1016/j.euroneuro.2012.01.005

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  9 in total

Review 1.  Crosstalk between epigenetic readers regulates the MOZ/MORF HAT complexes.

Authors:  Brianna J Klein; Marie-Eve Lalonde; Jacques Côté; Xiang-Jiao Yang; Tatiana G Kutateladze
Journal:  Epigenetics       Date:  2013-10-29       Impact factor: 4.528

2.  Chromatin profiling in human neurons reveals aberrant roles for histone acetylation and BET family proteins in schizophrenia.

Authors:  Lorna A Farrelly; Shuangping Zheng; Nadine Schrode; Aaron Topol; Natarajan V Bhanu; Ryan M Bastle; Aarthi Ramakrishnan; Jennifer C Chan; Bulent Cetin; Erin Flaherty; Li Shen; Kelly Gleason; Carol A Tamminga; Benjamin A Garcia; Haitao Li; Kristen J Brennand; Ian Maze
Journal:  Nat Commun       Date:  2022-04-22       Impact factor: 17.694

3.  Inactivation of the Schizophrenia-associated BRD1 gene in Brain Causes Failure-to-thrive, Seizure Susceptibility and Abnormal Histone H3 Acetylation and N-tail Clipping.

Authors:  Johan Palmfeldt; Jane Hvarregaard Christensen; Veerle Paternoster; Anders Valdemar Edhager; Per Qvist; Julie Grinderslev Donskov; Pavel Shliaha; Ole Nørregaard Jensen; Ole Mors; Anders Lade Nielsen; Anders Dupont Børglum
Journal:  Mol Neurobiol       Date:  2021-05-31       Impact factor: 5.590

4.  DNA Methylation Analysis of BRD1 Promoter Regions and the Schizophrenia rs138880 Risk Allele.

Authors:  Mads Dyrvig; Per Qvist; Jacek Lichota; Knud Larsen; Mette Nyegaard; Anders D Børglum; Jane H Christensen
Journal:  PLoS One       Date:  2017-01-17       Impact factor: 3.240

5.  Reduced Brd1 expression leads to reversible depression-like behaviors and gene-expression changes in female mice.

Authors:  Anto P Rajkumar; Per Qvist; Julie G Donskov; Ross Lazarus; Jonatan Pallesen; Nicoletta Nava; Gudrun Winther; Nico Liebenberg; Sanne H la Cour; Veerle Paternoster; Tue Fryland; Johan Palmfeldt; Kim Fejgin; Arne Mørk; Mette Nyegaard; Bente Pakkenberg; Michael Didriksen; Jens R Nyengaard; Gregers Wegener; Ole Mors; Jane H Christensen; Anders D Børglum
Journal:  Transl Psychiatry       Date:  2020-07-17       Impact factor: 6.222

6.  DNA methylation epi-signature is associated with two molecularly and phenotypically distinct clinical subtypes of Phelan-McDermid syndrome.

Authors:  L C Schenkel; E Aref-Eshghi; K Rooney; J Kerkhof; M A Levy; H McConkey; R C Rogers; K Phelan; S M Sarasua; L Jain; R Pauly; L Boccuto; B DuPont; G Cappuccio; N Brunetti-Pierri; C E Schwartz; B Sadikovic
Journal:  Clin Epigenetics       Date:  2021-01-06       Impact factor: 6.551

7.  The psychiatric risk gene BRD1 modulates mitochondrial bioenergetics by transcriptional regulation.

Authors:  Veerle Paternoster; Cagla Cömert; Louise Sand Kirk; Sanne Hage la Cour; Tue Fryland; Paula Fernandez-Guerra; Magnus Stougaard; Jens Randel Nyengaard; Per Qvist; Peter Bross; Anders Dupont Børglum; Jane Hvarregaard Christensen
Journal:  Transl Psychiatry       Date:  2022-08-08       Impact factor: 7.989

8.  Identification of the BRD1 interaction network and its impact on mental disorder risk.

Authors:  Tue Fryland; Jane H Christensen; Jonatan Pallesen; Manuel Mattheisen; Johan Palmfeldt; Mads Bak; Jakob Grove; Ditte Demontis; Jenny Blechingberg; Hong Sain Ooi; Mette Nyegaard; Mads E Hauberg; Niels Tommerup; Niels Gregersen; Ole Mors; Thomas J Corydon; Anders L Nielsen; Anders D Børglum
Journal:  Genome Med       Date:  2016-05-03       Impact factor: 11.117

9.  Dissecting the Epigenetic Changes Induced by Non-Antipsychotic Mood Stabilizers on Schizophrenia and Affective Disorders: A Systematic Review.

Authors:  Manuel Gardea-Resendez; Mehmet Utku Kucuker; Caren J Blacker; Ada M-C Ho; Paul E Croarkin; Mark A Frye; Marin Veldic
Journal:  Front Pharmacol       Date:  2020-04-22       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.